Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: report of a case and review of the literature

ConclusionsCarbapenem-based regimen of combination therapy, seems to be an option to treat patients infected withKlebsiella pneumoniae resistant to ceftazidime/avibactam and susceptible to carbapenem, at least when the risk of mortality is low.
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research